Core Insights - REX American Resources reported record ethanol sales volume for fiscal 2025, with 290 million gallons sold, slightly up from 289.7 million gallons in fiscal 2024 [2][4][7] - The company characterized fiscal 2025 as "exceptional" and "transformative," highlighting strong export demand and a solid balance sheet with no bank debt [3][5] - The fourth quarter saw a significant increase in net income attributable to shareholders, reaching $43.7 million compared to $11.1 million in the previous year [12][13] Financial Performance - Gross profit for fiscal 2025 was $93.7 million, an increase from $91.5 million in fiscal 2024, with fourth-quarter gross profit rising to $28.9 million from $17.6 million [9] - SG&A expenses increased to $32.6 million in fiscal 2025 from $27.1 million in fiscal 2024, with fourth-quarter SG&A rising to about $12.3 million from $6.2 million [10] - Net income attributable to REX shareholders for fiscal 2025 was $83.0 million, up from $58.2 million in fiscal 2024, with diluted EPS reaching an all-time high of $2.50 [12][13] Co-Product Performance - Dried distillers grains (DDGs) sales volume decreased by 3% to 612,000 tons in fiscal 2025, with fourth-quarter volume declining about 9% year over year [1] - Modified distillers grains volume increased to 81,900 tons in fiscal 2025 from about 70,000 tons in fiscal 2024, with an average selling price of approximately $65.82 per ton [7] - Corn oil sales increased to approximately 97.0 million pounds in fiscal 2025, up from 88.1 million pounds in fiscal 2024, with an average selling price of $0.54 per pound [8] Expansion and Initiatives - The One Earth Energy expansion project is nearing completion, expected to reach 200 million gallons annual capacity by fiscal 2026 [6][15] - The carbon capture facility is complete but awaiting permits for the Class VI well and pipeline, with the company engaged with regulatory bodies [16][17] - REX has invested approximately $166 million in carbon capture and ethanol expansion projects, remaining within its budget of $220 million to $230 million [18] Market Environment and Outlook - The company anticipates a profitable start to fiscal 2026, supported by strong exports and the benefits from the 45Z tax credit [5][19] - Management noted that U.S. ethanol export volumes reached record levels in 2025, with continued strength into 2026 [20] - Favorable corn supplies are expected to support manageable input costs and healthy crush margins [21]

Investor Event 2026 Investor Event 2026 Dimitri de Vreeze CEO 1 Journey Final step in our transformation journey First step as a higher-quality, more focused business A Category of One Innovation and creation-led growth, backed by science & sustainability Tune Prioritization of high-growth, high- margin segments with a calibrated steering approach Focus Full focus on building a leading consumer company in Nutrition, Health & Beauty Merge 2 iconic companies coming together Dream Bringing progress to life 1. ...

Core Insights - Balchem Plant Nutrition has launched the Metalosate T.E.A.M.™ digital platform to assist specialty crop advisors in optimizing nutrient balance, enhancing yield potential, and improving crop quality while minimizing input costs [1][5]. Group 1: Product Overview - The T.E.A.M. platform stands for Technical Evaluation of Albion Minerals and is based on decades of Balchem's research, utilizing plant tissue analysis to evaluate nutrient concentrations against optimal crop-specific ranges [2]. - T.E.A.M. simplifies the interpretation of complex plant tissue analysis results, providing actionable micronutrient recommendations rather than just data points [3]. Group 2: Benefits and Impact - Field trials indicate that T.E.A.M.-guided programs have led to measurable improvements in yield, quality, and profitability compared to addressing single nutrient deficiencies [4]. - The platform allows advisors to integrate plant tissue data into early season planning and in-season crop management strategies, catering to the needs of specialty crop growers for greater accuracy and confidence in input decisions [5]. Group 3: Features and Accessibility - T.E.A.M. archives historical tissue analysis data, enabling advisors to track nutrient trends over time, which supports informed decision-making and reduces unnecessary applications [6]. - The platform is available for free to pest control advisors and agronomists in the U.S. who work with specialty crops such as tree nuts, tree fruits, berries, and vines [7]. Group 4: Company Background - Balchem Corporation specializes in developing, manufacturing, and marketing specialty ingredients that enhance health and well-being across various industries, with three main business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products [8].

Company Overview - Balchem Corporation is a leading provider of specialty ingredients and performance products, with over $1.0 billion in trailing twelve-month revenue and a diversified customer base [6] - The company utilizes advanced encapsulation and formulation technologies to deliver differentiated solutions for nutrition, health, and industrial markets [6] - Balchem's product portfolio includes microencapsulated nutrients, food and beverage systems, and sterilization agents, serving various sectors such as food, pharmaceuticals, and animal health [8] Financial Performance - For the year 2025, Balchem reported record net sales of $1 billion, an increase of 8.8%, and net earnings of $154.8 million, up 20.5% [10] - Adjusted EBITDA reached $274.9 million, and free cash flow hit a record $173.6 million [10] - The company maintained a gross margin of 35.6% in the fourth quarter despite input cost pressures [10] Market Position - As of February 17, 2026, Balchem's shares were priced at approximately $180, reflecting an 8% increase over the past year, which is lower than the S&P 500's 16% gain [7] - Balchem represents 1.6% of Harvey Partners' 13F reportable AUM of $1.13 billion, indicating a strategic addition to the fund's portfolio [7] - The company has a solid balance sheet, with cash at $74.6 million and net debt leverage at just 0.3 times adjusted EBITDA [11] Investment Appeal - The addition of Balchem to a portfolio primarily focused on cyclical industrial and equipment names provides a steady compounder with durable growth potential tied to nutrition and health trends [9][12] - The company's strong competitive position within the specialty chemicals sector is supported by its pricing power and recurring demand [12]

Company Overview - Balchem Corporation is a global specialty ingredient manufacturer focused on health and nutrition markets [2] - The company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products [2] - The Human Nutrition & Health segment provides customized food and beverage ingredient systems and key nutrients for food, supplement, and pharmaceutical applications [2] - The Animal Nutrition & Health segment supplies products to various animal health markets [2] - Specialty Products offers specialty-packaged chemicals for healthcare and other industries, as well as chelated minerals for the micronutrient agricultural market [2] Upcoming Events - Balchem Corporation will participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026 [1] - Key executives attending the conference include Ted Harris (Chairman, President, and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director of Investor Relations) [1]

Core Insights - Kerry is a global leader in the B2B specialty ingredients market, demonstrating a strong track record of growth [1] - The company has recently achieved significant volume growth and market outperformance, attributed to its unique positioning as an innovation partner in the food and beverage sector [1] - Under the leadership of CEO Edmond Scanlon, Kerry has transformed into a pure-play taste and nutrition company, resulting in substantial margin expansion [1] Company Leadership - CEO Edmond Scanlon is leading the transformation of Kerry into a focused taste and nutrition company [1] - The executive team includes Chief Financial Officer Marguerite Larkin, Vice President of Marketing for North America Elizabeth Horvath, and William Lynch, Head of Investor Relations [1]

Summary of Kerry's Conference Call Company Overview - **Company**: Kerry Group - **Industry**: B2B Specialty Ingredients for Food and Beverage - **Revenue**: EUR 7 billion - **Global Presence**: 119 manufacturing facilities across 34 countries, reaching nearly 1.5 billion consumers globally [4][6] Core Points and Arguments Strategic Focus - Kerry aims to deliver high single-digit earnings growth through consistent volume growth and margin expansion [3][6] - The company has transformed into a pure-play taste and nutrition company under CEO Edmond Scanlon, leading to significant margin expansion [1][4] Financial Performance - Revenue growth from EUR 4 billion in 2017 to EUR 7 billion today, with a target of high single-digit earnings compounding [6] - Achieved double-digit adjusted earnings per share growth on average since 1986, with high single-digit growth in 8 of the last 10 years [6] - EBITDA margin expanded by over 300 basis points in the past four years, targeting 19%-20% by 2028 [7][49] Market Dynamics - The food and beverage market is dynamic, with over 70% of global consumers reporting changes in preferences over the last three years [22][23] - High protein products are growing at over 7% CAGR, while non-protein products remain in low single digits [24] - Over 60% of new food and beverage activity involves reformulation, driven by cost reduction and clean label demands [13][14] Innovation and Renovation - Kerry is positioned at the intersection of innovation and renovation, helping customers create new products while transforming existing ones [14] - Significant investments in biotechnology, with over EUR 3 billion in science and technology over the last decade [5][11] - Recent innovations include fermentation-derived technologies for taste and health benefits, such as sweet and salt reduction technologies [12] Regional Performance - **Americas**: Consistent volume growth of 3%-4%, with strong market outperformance due to customer access and tailored go-to-market strategies [16] - **APMEA**: Revenues over EUR 1.6 billion, with significant growth in Southeast Asia and the Middle East, focusing on local culture and authentic flavors [18] Regulatory Landscape - Global front-of-pack nutritional labeling regulations are expanding, creating opportunities for Kerry in product reformulation [20] Additional Important Content - Kerry's Accelerate 2.0 program aims to drive operational excellence and margin expansion, with a target of EUR 100 million in annual benefits by 2028 [42][45] - The company maintains a balanced capital allocation strategy, investing 4%-5% of revenues in growth while returning capital to shareholders through dividends and share buybacks [46][48] - Sustainability efforts include a 52% reduction in carbon emissions and a 54% reduction in food waste [39] Conclusion - Kerry is well-positioned to capitalize on market dynamics through innovation and renovation, with a strong focus on biotechnology and customer partnerships, aiming for continued earnings growth and market outperformance [50]

Core Insights - Hawkins, Inc. will participate in the Raymond James & Associates' 47th Annual Institutional Investors Conference on March 3 and 4, 2026, in Orlando, Florida, with CEO Patrick Hawkins and CFO Jeff Oldenkamp attending [1][3]. Company Overview - Hawkins, Inc. is a leading water treatment and specialty ingredients company, founded in 1938, headquartered in Roseville, Minnesota, and operates 65 facilities across 28 states [4]. - The company generated $974 million in revenue for fiscal 2025 and employs approximately 1,100 people [4]. Conference Details - The Raymond James Institutional Investors Conference serves as a platform for portfolio managers to explore investment opportunities across various industries, with the 2025 conference attracting around 2,000 attendees from nearly 900 institutional investment firms [2]. - The 2026 conference will feature presentations from senior management teams of approximately 300 companies, providing insights into both the companies and their respective industry sectors [2].

Core Insights - Hawkins, Inc. reported record results in revenue, gross profit, operating income, and Adjusted EBITDA for the third quarter of fiscal 2026, driven by acquisition activity in the Water Treatment segment and improvements in the Industrial Solutions segment [3][5]. Financial Performance - Revenue for the third quarter reached $244.1 million, an increase of 8% from $226.2 million in the same period last year, with Water Treatment segment growth of 21% and Industrial Solutions segment growth of 10% [5][7]. - Gross profit increased by 5% to $50.8 million, maintaining a gross margin of 21% [5][11]. - Adjusted EBITDA was $34.8 million, a 3% increase from the previous year, with a trailing 12-month Adjusted EBITDA of $179 million [5][17]. Earnings and Expenses - Diluted earnings per share (EPS) were $0.69, a decrease of 4% due to increased amortization and interest expenses related to acquisitions [5][6]. - Selling, general, and administrative (SG&A) expenses rose by 3% to $28.3 million, accounting for 12% of sales, influenced by costs from acquired businesses [15]. Segment Performance - The Water Treatment segment reported sales of $120.5 million, up 21% from $99.8 million, attributed to $19 million from acquired businesses and improved pricing [8]. - The Food & Health Sciences segment saw a decline in sales by 10% to $70.0 million, primarily due to decreased sales volumes [9]. - The Industrial Solutions segment's sales increased by 10% to $53.6 million, driven by higher sales of manufactured products [10]. Cash Flow and Debt Management - Operating cash flow for the quarter was $35 million, with $15 million used to pay down debt, resulting in a leverage ratio of 1.47x Adjusted EBITDA [5][19]. - Total debt outstanding at the end of the quarter was $264 million, reflecting a strategic focus on reducing leverage [19]. Future Outlook - The company anticipates continued pricing pressures in the Food and Health Sciences segment but expects to return to historical organic revenue growth rates in fiscal 2027 [3].

Company Overview - Hawkins, Inc. is a leading water treatment and specialty ingredients company founded in 1938, headquartered in Roseville, Minnesota [2] - The company operates 65 facilities across 28 states and employs approximately 1,100 people [2] - In fiscal 2025, Hawkins, Inc. generated $974 million in revenue [2] Dividend Announcement - The Board of Directors declared a quarterly cash dividend of $0.19 per share, payable on February 27, 2026 [1] - Shareholders of record will be those on the books at the close of business on February 13, 2026 [1] - Hawkins, Inc. has consistently paid dividends since 1985, indicating a long-standing commitment to returning value to shareholders [1]